Business:
Novel treatments for gastrointestinal diseases and disorders
Drug notes:
Also NDA errosive GERD, heartburn, Clin3 heartburn in non-erosive GERD, different dosing Clin2 heartburn in non-erosive GERD, Clin2 eosinophilic esophagitis
About:
Phathom Pharmaceuticals is dedicated to improving treatments for gastrointestinal (GI) diseases. They focus on developing innovative therapies for acid-related disorders like ulcers and heartburn. One key area of their research is the development of new proton pump inhibitors – a class of drugs that reduce stomach acid production. While there are existing PPIs on the market, Phathom is investigating more effective and potentially longer-lasting options. This could lead to improved patient outcomes and potentially reduce the need for frequent medication use.
******* ******* ******* (***) ******** - **** ****** ******|8 days ago
Regional Sales Manager - AZ/CO United States|18 days ago
Regional Sales Manager - IN/IL United States|18 days ago
Territory Sales Representative Norfolk, VA|30 days ago
******** ***** ******* - ********* (**, **, **, **... ****** ******|30 days ago
Territory Sales Representative Livonia, MI|67 days ago
Regional Sales Manager - New York City United States|100+ days ago